Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership announcements that further the company’s commitment to unlocking the power of the genome. Speaking today at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, Illumina CEO, … [Read more...] about Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics